Blue Water Life Science Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25M | Hold |
2,145,145
| – | – | 19.78% | 2 |
|
|
2025
Q1 | $15.9M | Hold |
2,145,145
| – | – | 15.79% | 3 |
|
|
2024
Q4 | $12.9M | Hold |
2,145,145
| – | – | 11.39% | 4 |
|
|
2024
Q3 | $11M | Buy |
+2,145,145
| New | +$11M | 9.66% | 5 |
|
|
2024
Q2 | – | Sell |
-1,687,665
| Closed | -$5.42M | – | 9 |
|
|
2024
Q1 | $5.42M | Hold |
1,687,665
| – | – | 5.1% | 6 |
|
|
2023
Q4 | $8.27M | Sell |
1,687,665
-690,000
| -29% | -$3.38M | 7.24% | 7 |
|
|
2023
Q3 | $13M | Sell |
2,377,665
-652,769
| -22% | -$3.56M | 12.23% | 4 |
|
|
2023
Q2 | $20.3M | Hold |
3,030,434
| – | – | 13.72% | 4 |
|
|
2023
Q1 | $26.8M | Hold |
3,030,434
| – | – | 17.69% | 2 |
|
|
2022
Q4 | $23.2M | Sell |
3,030,434
-570,000
| -16% | -$4.35M | 15.55% | 3 |
|
|
2022
Q3 | $25.6M | Buy |
3,600,434
+480,000
| +15% | +$3.42M | 10.35% | 5 |
|
|
2022
Q2 | $25.2M | Buy |
+3,120,434
| New | +$25.2M | 13.71% | 4 |
|
|
2021
Q2 | – | Sell |
-251,695
| Closed | -$10.1M | – | 24 |
|
|
2021
Q1 | $10.1M | Buy |
251,695
+43,595
| +21% | +$1.76M | 4.95% | 7 |
|
|
2020
Q4 | $12.3M | Buy |
+208,100
| New | +$12.3M | 7.22% | 6 |
|